Pfizer
PFE
#134
Rank
NZ$251.26 B
Marketcap
NZ$44.19
Share price
-0.87%
Change (1 day)
4.17%
Change (1 year)

Pfizer Inc., is a global pharmaceutical company headquartered in New York City, New York, United States. It was founded by Charles Pfizer from Ludwigsburg. Pfizer is the second largest pharmaceutical company in the world after Roche, followed by Novartis.

Market capitalization of Pfizer (PFE)

Market cap: NZ$251.26 Billion

As of December 2025 Pfizer has a market cap of NZ$251.26 Billion. This makes Pfizer the world's 134th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Pfizer from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$251.26 B-6.06%
2024NZ$267.48 B4.06%
2023NZ$257.05 B-43.26%
2022NZ$453.02 B-6.64%
2021NZ$485.24 B71.12%
2020NZ$283.56 B-11.92%
2019NZ$321.94 B-13.46%
2018NZ$372.02 B22.38%
2017NZ$303.99 B6.84%
2016NZ$284.54 B-2.3%
2015NZ$291.23 B16.44%
2014NZ$250.10 B4.86%
2013NZ$238.51 B7.53%
2012NZ$221.81 B4.07%
2011NZ$213.13 B17.21%
2010NZ$181.84 B-10.02%
2009NZ$202.10 B-1.79%
2008NZ$205.78 B2.57%
2007NZ$200.62 B-23.4%
2006NZ$261.90 B4.28%
2005NZ$251.14 B-10.82%
2004NZ$281.61 B-32.08%
2003NZ$414.63 B15.2%
2002NZ$359.93 B-40.25%
2001NZ$602.38 B-8.09%
2000NZ$655.40 B174.48%
1999NZ$238.78 B-22.2%
1998NZ$306.92 B84.6%
1997NZ$166.26 B119.42%
1996NZ$75.77 B

End of Day market cap according to different sources

On Dec 8th, 2025 the market cap of Pfizer was reported to be:

NZ$253.62 Billion
by Nasdaq info icon info icon
NZ$253.48 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Merck
MRK
NZ$419.06 B 66.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$839.38 B 234.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$179.17 B-28.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.536 T 511.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$438.32 B 74.45%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
GlaxoSmithKline
GSK
NZ$166.88 B-33.58%๐Ÿ‡ฌ๐Ÿ‡ง UK
Amgen
AMGN
NZ$295.77 B 17.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$366.13 B 45.72%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$482.89 B 92.18%๐Ÿ‡ฌ๐Ÿ‡ง UK